A 72-year-old woman on warfarin for atrial fibrillation (INR 4.2) presents with acute onset left-sided weakness and global aphasia. CT head shows a right frontal lobar hemorrhage (45 mL) with surrounding edema but no intraventricular extension. Her platelet count is 180,000/µL, and coagulation studies show PT 28 seconds (INR 4.2), aPTT 38 seconds, and fibrinogen 280 mg/dL. Which intervention is most critical in the first 30 minutes to limit hematoma expansion?

Explanation

## Management of Warfarin-Associated Intracerebral Hemorrhage ### Pathophysiology of Anticoagulant-Related ICH **Key Point:** Warfarin inhibits vitamin K–dependent factors (II, VII, IX, X). In ICH, rapid reversal of anticoagulation is critical because hematoma expansion occurs in 30–40% of patients within the first few hours, correlating with poor outcomes. ### Reversal Strategies for Warfarin-Associated ICH | Agent | Mechanism | Onset | Duration | Indication | |-------|-----------|-------|----------|------------| | **FFP 15 mL/kg** | Replaces vit K–dependent factors directly | 30–60 min | 4–6 hrs | First-line if PCC unavailable; slower but universally available | | **Prothrombin Complex Concentrate (PCC)** | Concentrated vit K factors II, VII, IX, X | 15–30 min | 12–24 hrs | **Preferred** if available; faster, smaller volume | | **Vitamin K 10 mg IV** | Induces hepatic synthesis of vit K factors | 12–24 hrs | Days | **Must give with FFP/PCC**; alone too slow | | **Idarucizumab** | Direct Factor Xa inhibitor reversal | 5–10 min | 45 min | For dabigatran only; NOT for warfarin | | **Tranexamic acid** | Antifibrinolytic; reduces fibrinolysis | 10–15 min | 3–5 hrs | Adjunctive; may reduce expansion but NOT primary reversal | ### Why FFP + Vitamin K is Correct 1. **FFP 15 mL/kg** immediately replaces warfarin-dependent factors (II, VII, IX, X) - Onset: 30–60 minutes - Effective in lowering INR from 4.2 to <1.5 within 1–2 hours - Universally available in all hospitals 2. **Vitamin K 10 mg IV** (slow infusion, never bolus) - Induces hepatic synthesis of factors - Onset: 12–24 hours (too slow alone) - **Must be given WITH FFP** to sustain reversal after FFP wears off (4–6 hrs) - Prevents rebound anticoagulation **High-Yield:** The combination of **FFP + Vitamin K** is the standard of care when PCC is unavailable. PCC is preferred if available (faster, smaller volume), but FFP is universally accessible and acceptable. ### Clinical Pearl: Hematoma Expansion Risk - **Warfarin-associated ICH** has higher expansion risk (30–40%) than spontaneous ICH - **Goal INR:** <1.5 within 24 hours - **Goal PT:** <15 seconds - Rapid reversal within 30–60 minutes correlates with reduced hematoma growth and better outcomes ### Why Each Distractor Is Wrong **Platelet transfusion + cryoprecipitate:** - Platelet count is normal (180,000/µL); transfusion is unnecessary - Cryoprecipitate replaces fibrinogen, but fibrinogen is adequate (280 mg/dL; normal >100) - Does NOT reverse warfarin effect; wrong mechanism **Idarucizumab:** - Idarucizumab is a **direct Factor IIa (thrombin) inhibitor reversal agent** - Used exclusively for **dabigatran** (a direct thrombin inhibitor), NOT warfarin - Warfarin is a vitamin K antagonist; idarucizumab has no effect **Tranexamic acid:** - Antifibrinolytic; reduces secondary fibrinolysis - May have adjunctive benefit in reducing hematoma expansion (CRASH-3 trial in TBI) - **NOT a reversal agent** and does NOT correct INR - Should NOT be used as monotherapy for anticoagulation reversal ```mermaid flowchart TD A["Warfarin-associated ICH<br/>INR > 2"]:::outcome --> B{"PCC available?"}:::decision B -->|Yes| C["PCC 25 U/kg IV<br/>+ Vitamin K 10 mg IV"]:::action B -->|No| D["FFP 15 mL/kg IV<br/>+ Vitamin K 10 mg IV"]:::action C --> E["Recheck INR at 30 min<br/>Goal INR < 1.5"]:::action D --> E E --> F{"INR corrected?"}:::decision F -->|Yes| G["Supportive care<br/>Neuroimaging q6h"]:::action F -->|No| H["Repeat FFP or PCC"]:::action H --> E ``` **Warning:** Vitamin K must NEVER be given as an IV bolus (risk of anaphylaxis); always use slow IV infusion over 10–20 minutes.